Synergistic or strong synergistic effects were also observed in the lung cancer cell line NCI-H1417 with frameshift mutation in TP53 and no expression of full-length p53 (Table 1a; Supplementary Figure S3). The gene discussed is TP53; the disease is lung carcinoma.